Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
---|---|---|---|---|
Total Revenue | 1,600,979 | 2,841,856 | 1,483,794 | 1,657,421 |
Cost of Revenue | 1,351,303 | 2,383,202 | 1,225,952 | 1,367,196 |
Gross Profit | 249,676 | 458,654 | 257,842 | 290,225 |
Operating Expenses | ||||
Research Development | -- | -- | -- | -- |
Selling General and Administrative | -- | 133,602 | 58,295 | 67,137 |
Non Recurring | -- | -- | -- | -- |
Others | 221,875 | 287,944 | 182,891 | 157,510 |
Total Operating Expenses | 221,875 | 421,546 | 241,186 | 224,647 |
Operating Income or Loss | 27,801 | 37,108 | 16,656 | 65,578 |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (3,063) | (43,718) | (611) | (1,746) |
Earnings Before Interest And Taxes | 21,082 | 67,882 | 23,058 | 69,342 |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | (16,121) | (4,722) | (18,095) | 30,472 |
Income Tax Expense | 16,953 | -- | 4,535 | 7,673 |
Minority Interest | 28,962 | 53,488 | 29,982 | 31,213 |
Net Income From Continuing Ops | (33,074) | (4,722) | (22,630) | 22,799 |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | (1,208) | (92) | 2,854 | (2,902) |
Net Income | (34,282) | (4,814) | (19,776) | 19,897 |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | (34,282) | (4,814) | (19,776) | 19,897 |